Michael P. Cruse
2021
In 2021, Michael P. Cruse earned a total compensation of $1.5M as Chief Operating Officer at Reneo Pharmaceuticals.
Compensation breakdown
| Bonus | $40,000 |
|---|---|
| Non-Equity Incentive Plan | $83,300 |
| Option Awards | $1,072,736 |
| Salary | $300,000 |
| Total | $1,496,036 |
Cruse received $1.1M in option awards, accounting for 72% of the total pay in 2021.
Cruse also received $40K in bonus, $83.3K in non-equity incentive plan and $300K in salary.
Rankings
In 2021, Michael P. Cruse's compensation ranked 7,278th out of 12,415 executives tracked by ExecPay. In other words, Cruse earned more than 41.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,278 out of 12,415 | 41st |
Division Manufacturing | 3,194 out of 5,508 | 42nd |
Major group Chemicals And Allied Products | 1,417 out of 2,378 | 40th |
Industry group Drugs | 1,261 out of 2,099 | 40th |
Industry Pharmaceutical Preparations | 927 out of 1,549 | 40th |
Source: SEC filing on April 22, 2022.
Cruse's colleagues
We found two more compensation records of executives who worked with Michael P. Cruse at Reneo Pharmaceuticals in 2021.